Back to News
Market Impact: 0.42

ATS (ATS) Q4 2026 Earnings Call Transcript

Corporate EarningsCorporate Guidance & OutlookM&A & RestructuringCompany FundamentalsTransportation & LogisticsHealthcare & BiotechTechnology & InnovationTax & Tariffs

ATS reported Q4 adjusted revenue of $744 million, up 3.2%, with adjusted earnings from operations rising 3.4% to $76.8 million and gross margin improving 36 bps to 29.4%. Full-year revenue and adjusted operating earnings grew about 11%, backlog ended near $2 billion, and leverage improved to 2.8x, but bookings fell 18.4% and fiscal 2027 guidance calls for only modest revenue growth due to a $50 million transportation revenue step-down. Management is targeting 50-75 bps of margin expansion next year while continuing restructuring, with Life Sciences, Energy, and recurring revenue initiatives remaining key supports.

Analysis

ATS is in the middle of a portfolio-quality upgrade rather than a simple cyclical rerate. The transportation exit matters less for the near-term revenue headline than for what it does to mix: it strips out low-return volume, raises the share of regulated end markets, and should mechanically improve operating leverage as services and aftermarket become a bigger denominator. That creates a cleaner path to margin accretion over the next 2-4 quarters, even if reported growth looks softer while backlog normalizes.

The bigger second-order effect is capital discipline becoming a competitive weapon. With leverage back in range and working capital below target, ATS can now fund both restructuring and selective M&A without stressing the balance sheet, which is rare among industrial automation peers. That should widen the gap versus smaller private competitors that cannot self-fund service integration, digital tools, and nuclear/radiopharma capability expansion at the same time.

The market is likely underestimating how much of the FY27 guide is timing-driven versus demand-driven. Bookings volatility is masking healthier underlying demand in energy and life sciences, but the more important tell is the shift toward recurring revenue and lifecycle ownership, which lowers earnings beta and should reduce multiple discount over time. The contrarian risk is execution: if integration savings lag or large-project timing slips again, the market will treat the transportation repositioning as self-inflicted revenue shrinkage rather than a value-enhancing reset.

Net: this is a longer-duration re-rate candidate, not a quick print trade. The stock should work best if management can show sequential margin improvement and stable order conversion through Q1/Q2 while proving the restructuring is funding growth, not just offsetting decay.